Can fish oil maintain Crohn's disease in remission?

Nutrition Reviews

Volumn 54, Issue 8, 1996, Pages 248-252

  Kim, Young In ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL;

CROHN DISEASE; DIET SUPPLEMENTATION; HEALTH PROMOTION; HUMAN; RELAPSE; REMISSION; SHORT SURVEY;

EID: 0029989340     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.1996.tb03943.x     Document Type: Short Survey

References (30)

1. Hanauer SB. Inflammatory bowel disease. N Engl J Med 1996;334:841-8
2. Greenberg GR. Nutritional support in inflammatory bowel disease: current status and future directions. Scand J Gastroenterol 1992;27(Suppl 192):117-22
3. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology 1995;108:1056-67
4. Ostro MJ, Greenberg GR, Jeejeebhoy KN. Total parenteral nutrition and complete bowel rest in the management of Crohn's disease. JPEN 1985;9:280-7
5. Sitzmann JV, Converse RL, Bayless TM. Favorable response to parenteral nutrition and medical therapy in Crohn's colitis. Gastroenterology 1990;99:1647-52
6. Breuer RI, Buto SK, Christ ML, et al. Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Preliminary report. Dig Dis Sci 1991;36:185-7
7. Salomon P, Kombluth AA, Janowitz HD. Treatment of ulcerative colitis with fish oil n-3-omega-fatty acid: an open trial. J Clin Gastroenterol 1990;12:157-61
8. Lorenz R, Weber PC, Szimnau P, Heldwein W, Strasser T, Loeschke K. Supplementation with n-3 fatty acids from fish oil in chronic inflammataory bowel disease - a randomized, placebo-controlled, double-blind cross-over trial. J Intern Med 1989;225(Suppl):225-32
9. Stenson WF, Cort D, Rodgers J, et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 1992;116:609-14
10. Asian A, Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroenterol 1992;87:432-7
11. Hawthorne AB, Daneshmend TK, Hawkey CJ, et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 1992;33:922-8
12. Mate J, Castanos R, Garcia-Samaniego J, Pajares JM. Does dietary fish oil maintain the remission of Crohn's disease: a study case control. Gastroenterology 1991;100(Abstr):A228
13. Stansby ME. Nutritional properties of fish oils. World Rev Nutr Diet 1969;11:46-105
14. Lee TH, Hoover RL, Williams JD, et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985;312:1217-24
15. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrossi factor by mononuclear cells. N Engl J Med 1989;320:265-71
16. Fisher M, Upchurch KS, Levine PH, et al. Effects of dietary fish oil supplementation on polymorphonuclear leucocyte inflammatory potential. Inflammation 1986;10:387-92
17. Bittiner SB, Tucker WFG, Cartwright SS, Bleehan SS. A double-blind randomized placebo-controlled trial of fish oil in psoriasis. Lancet 1988;i:378-80
18. Bjorneboe A, Soyland E, Bjorneboe G-EA, Rajka G, Drevon CA. Effect of dietary supplementation with eicosapentaenoic acid in the treatment of atopic dermatitis. Br J Dermatol 1987;117:463-9
19. Kremer JM, Jubiz W, Michalek A, et al. Fish oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded controlled crossover study. Ann Intern Med 1987;106:497-503
20. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996;334:1557-60
21. Brignola C, Campieri M, Bazzocchi G, Farruggia P, Tragnone A, Lanfranchi GA. A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease. Gastroenterology 1986;91:1490-4
22. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 1976;70;439-44
23. Modigliani R, Mary J-Y, Simon J-F, et al. Clinical, biological and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Gastroenterology 1990;98:811-8
24. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990;99:956-64
25. Messori A, Brignola C, Trallori G, et al. Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis. Am J Gastroenterol 1994;89:692-8
26. Sachar DB. Maintenance therapy in ulcerative colitis and Crohn's disease. J Clin Gastroenterol 1995;20: 117-22
27. Stark ME, Tremaine WJ. Maintenance of symptomatic remission in patients with Crohn's disease. Mayo Clin Proc 1993;68:1183-90
28. Appel LJ, Miller ER III, Seidler AJ, Whelton PK. Does supplementation of diet with "fish oil" reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 1993;153:1429-38
29. O'Connor GT, Malenka DJ, Olmstead Em, Johnson PS, Hennekens CH. A meta-analysis of randomized trials of fish oil in prevention of restenosis following coronary angioplasty. Am J Prev Med 1992;8:186-92
30. Caygill CP, Hill MJ. Fish, n-3 fatty acids and human colo/rectal and breast cancer mortality. Eur J Cancer Prev 1995;4:329-32